HOME > COLUMN
COLUMN
- Goal-Setting for 2024: Crushing It
December 20, 2023
- The Power of Referrals and Who to Ask
November 24, 2023
- How Can Innovative Field Force Roles and Ways of Working Create More Impactful Engagement?
November 2, 2023
- 3 Strategies for Attracting Talent Who Aren’t Looking for a Job
October 18, 2023
- How Can You Improve Field Force Productivity in the Age of Digital? Omnichannel Excellence and the Importance of a Strong “Middle Layer”
October 6, 2023
- How to Get 4 Qualified Candidates within 4 Weeks
September 25, 2023
- How Far Has Your Organization Come? Key Lessons Learned from Ongoing Commercial Transformations in Japan
September 11, 2023
- Mission Impossible: Finding the Right Leader to Launch a Disruptive Medical Technology into Japan
August 10, 2023
- How Healthcare Companies Should Hire in the Post-COVID Work Environment
July 19, 2023
- The Impact of a Shrinking Labor Market on the Healthcare Industry
June 23, 2023
- Seven Recruitment Trends in 2023
May 31, 2023
- The Inflation Reduction Act - Implications for Japanese Pharmaceutical Manufacturers
May 19, 2023
- How to Serve and Get Ahead
April 21, 2023
- The Increasing Impact of Real-World Evidence
March 31, 2023
- Rewarding Value and Innovation and Ensuring Financial Viability of the Biopharmaceutical Supply Chain in Japan
March 16, 2023
- Why Market Mapping Is Critical to Your Organization
February 24, 2023
- When It Comes to Recruitment, Time Is Money. Have a Plan!
January 31, 2023
- Cell Therapy in Japan: A Potentially Attractive Market at a Turning Point Facing Challenges
December 16, 2022
- How to Succeed in Bad Times and Good
December 9, 2022
- The Pros and Cons of Working from Home in 2022
November 25, 2022
ページ
I recently attended a fantastic conference hosted by Prospection Japan, and one speaker, Dr. Joe Ledsam, really blew me away with his insights. He shared some truly fascinating developments about how AI is set to revolutionize healthcare, from how doctors…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…